Trade Flops After Cubs Inspect Luzardo’s Medical History

In a sudden turn of events, the highly anticipated trade between the Chicago Cubs and Miami Marlins for talented left-handed pitcher Jesús Luzardo broke down at the finish line. According to insider reports, the Cubs’ review of Luzardo’s medical history proved to be the deal-breaker.

Conversations for Luzardo occurred after the two-year agreement that the Cubs signed with Matthew Boyd on December 2. – Ken Rosenthal, The Athletic

Injury Concerns Raised Red Flags

Luzardo, who missed significant time last season due to an elbow inflammation and back stress, seemed poised to join the Cubs in mid-December. However, the Cubs must have discovered something in his medical reports that gave them second thoughts.

Marlins Quickly Find Alternate Trade Partner

Following the Cubs’ reticence, the Marlins swiftly found another suitor for Luzardo – the Philadelphia Phillies. On December 22, the Phillies acquired Luzardo in exchange for prospects Starlyn Caba, Emaarion Boyd, and minor league catcher Paul McIntosh.

Luzardo Assures Full Health

In his first press statements as a Phillie, Luzardo asserted he felt “100% throughout the offseason,” claiming his back injury had “completely solved” and was “back to normal.”

Phillies Unfazed by Medical Assessment

Despite the Cubs’ qualms, the Phillies seemed confident in their medical review of Luzardo, showcasing the variance in medical assessments between teams.

Luzardo Excels With Phillies Despite Trade Controversy

In a twist of fate, Luzardo has enjoyed a remarkable beginning with the Phillies. Posting a 2.08 ERA in 30.1 innings, he has struck out 30% of batters faced and has seen his fastball velocity increase slightly from his 2024 campaign.